About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
Dec 29, 2022... Prof. Alon Chen, President of the Weizmann Institute of Science, has been awarded the 2022 Bennett Family Award for Collaboration in the Science of Wellness, along with Juan de Pablo, the Executive Vice President for Science, Innovation, National Laboratories, and Global Initiatives, and the Liew Family Professor in Molecular Engineering at the Pritzker School of Molecular Engineering at the University of Chicago. Each year, the Bennett Family Award will recognize individuals engaged in collaborative research, merging science and wellness for the advancement of human health.
https://weizmann-usa.org/news-media/in-the-news/nasa-to-cooperate-on-israeli-astrophysics-mission/
Jan 25, 2023...
WASHINGTON — The United States and Israel are finalizing an agreement that would see NASA contribute to an upcoming Israeli astrophysics mission.
The focus of the agreement, which could be signed as soon as later this month, involves a mission called Ultrasat under development by Israel’s Weizmann Institute of Science with support from the Israel Space Agency and German research center DESY.
As part of the agreement, NASA would provide the launch of Ultrasat, which will operate in geostationary orbit. NASA will likely arrange to fly Ultrasat as a secondary payload on a commercial GEO launch, said James Rhoads, NASA project scientist for Ultrasat, during a session of the 241st Meeting of the American Astronomical Society Jan. 11.
Feb 21, 2023...
REHOVOT, ISRAEL—FEBRUARY 21, 2023 NASA will launch Israel’s first space telescope – the Ultraviolet Transient Astronomy Satellite, or ULTRASAT – into high-Earth orbit in early 2026, as part of a newly signed partnership between United States’ NASA and Israel's Ministry of Innovation, Science and Technology.
ULTRASAT, a premier project of the Israel Space Agency (ISA) in the Ministry of Innovation, Science and Technology and the Weizmann Institute of Science, is expected to revolutionize scientists’ ability to detect and analyze transient events in the universe, such as neutron star mergers and supernova explosions.
Feb 22, 2023... REHOVOT, ISRAEL—FEBRUARY 22, 2023 One of the striking aspects of the quantum world is that a particle, say, an electron, is also a wave, meaning that it exists in many places at the same time. In a new study, reported today in Nature, researchers from the Weizmann Institute of Science make use of this property to develop a new type of tool – the quantum twisting microscope (QTM) – that can create novel quantum materials while simultaneously gazing into the most fundamental quantum nature of their electrons. The study’s findings may be used to create electronic materials with unprecedented functionalities.
Feb 22, 2023...
One of the striking aspects of the quantum world is that a particle is also a wave. Quantum particles exist in many places and forms at the same time.
In a study titled “The Quantum Twisting Microscope” just published in the journal Nature, researchers from the Weizmann Institute of Science in Rehovot made use of this property to develop a new type of tool – the quantum twisting microscope (QTM) – that can create novel quantum materials while simultaneously gazing into the most fundamental nature of their electrons. The study’s findings may be used to create electronic materials with unprecedented functionalities.
https://weizmann-usa.org/blog/2023-impact-report-a-year-of-boundless-exploration/
Mar 08, 2023...
Through the generous support of our donors, Weizmann scientists and students made 2022 another stellar year of innovative research. You can learn all about it in the 2022 Impact Report from the Weizmann Institute of Science.
This new, digital-only publication highlights the phenomenal people, incredible achievements, and vital research advances at the Institute this past year.A digital format helps us reduce our environmental footprint, allows us to share videos, animations, and links, and makes it easy to forward the report to friends and family.
Apr 14, 2023... REHOVOT, ISRAEL—April 13, 2023 — The journey to Jupiter has begun. The European Space Agency’s unmanned spacecraft JUICE (short for JUpiter ICy moons Explorer) is launching today from Europe’s Spaceport in French Guiana. JUICE’s voyage, the ESA’s most ambitious mission to date, will be particularly lengthy: Upon reaching Jupiter’s orbit by 2031, it will embark on a four-year mission to investigate three of Jupiter’s moons – Callisto, Europa and Ganymede – as well as the composition of Jupiter’s atmosphere
Apr 13, 2023...
The European Space Agency's (ESA) landmark JUICE mission is set to depart for Jupiter on Thursday, April 13 – and some Israeli-made technology is on for the ride.
The Israeli participation is funded by the Israel Space Agency, which is under the auspices of the Science and Technology Ministry.
The JUICE mission, which stands for Jupiter Icy Moon Explorer, is set to embark on a 900 million-kilometer journey to the largest planet in the solar system, where it will spend four years exploring the moons of Ganymede, Callisto and Europa.
Apr 23, 2023... REHOVOT, ISRAEL—April 27, 2023—To get life-giving oxygen into every cell, the human body produces two to three million oxygen-carrying red blood cells, or erythrocytes, each second – about one-quarter of all the new cells that are produced in the body at any one time. This process is controlled by the hormone erythropoietin, commonly known as EPO, which works by binding to cells in the bone marrow that are poised to become erythrocytes, promoting their proliferation. Erythropoietin was discovered decades ago, but the identity of the cells that make this hormone remained unknown – until now.
May 24, 2023...
To get life-giving oxygen into every cell, the human body produces two to three million oxygen-carrying red blood cells each second, a process controlled by the hormone erythropoietin (EPO), which works by binding to cells in the bone marrow and promoting their proliferation. Discovered decades ago, the identity of the cells that make this hormone remained unknown – until now.
In a new paper, published in Nature Medicine, Weizmann scientists from Prof. Ido Amit’s lab and colleagues from Israel, Europe, and the United States have identified a rare subset of kidney cells that are the main producers of EPO in the human body, a discovery that has transformative potential for patients with anemia.
©2023 American Committee for the Weizmann Institute of Science
